These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 7738646)
1. Scintigraphic evaluation of pancreatic transplants using technetium-99m-sestamibi. Elgazzar AH; Munda R; Fernandez-Ulloa M; Clark J; Ryan JR; Hughes JA J Nucl Med; 1995 May; 36(5):771-7. PubMed ID: 7738646 [TBL] [Abstract][Full Text] [Related]
2. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT. Kiat H; Germano G; Friedman J; Van Train K; Silagan G; Wang FP; Maddahi J; Berman D J Nucl Med; 1994 Apr; 35(4):542-8. PubMed ID: 8151372 [TBL] [Abstract][Full Text] [Related]
3. Pancreas transplants: evaluation using perfusion scintigraphy. Kuni CC; du Cret RP; Boudreau RJ AJR Am J Roentgenol; 1989 Jul; 153(1):57-61. PubMed ID: 2500016 [TBL] [Abstract][Full Text] [Related]
4. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities. Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553 [TBL] [Abstract][Full Text] [Related]
6. The use of exercise technetium-99m 2-methoxy-isobutyl-isonitrile (99mTc-Sestamibi) perfusion scanning in the detection of acute rejection after cardiac transplantation. Mullins PA; Schofield PM; Dunning J; Scott J; Aravot D; Large S; Cary N; Wallwork J; Stone D J Nucl Biol Med (1991); 1992; 36(1):2-6. PubMed ID: 1450221 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi. Kapucu LO; Akyüz C; Vural G; Oguz A; Atasever T; Büyükpamukçu M; Unlü M J Nucl Med; 1997 Feb; 38(2):243-7. PubMed ID: 9025746 [TBL] [Abstract][Full Text] [Related]
9. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI). Li QS; Solot G; Frank TL; Wagner HN; Becker LC J Nucl Med; 1990 Jun; 31(6):1069-76. PubMed ID: 2140856 [TBL] [Abstract][Full Text] [Related]
10. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium 99m sestamibi. Rodney RA; Johnson LL; Blood DK; Barr ML J Heart Lung Transplant; 1994; 13(2):173-80. PubMed ID: 8031797 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of segmental necrosis in a pancreas transplant by thallium-201 perfusion scintigraphy. Hirsch H; Fernandez-Ulloa M; Munda R; Fisher RA; Moulton JS; Huth CJ J Nucl Med; 1991 Aug; 32(8):1605-7. PubMed ID: 1869986 [TBL] [Abstract][Full Text] [Related]
12. Inhomogeneity of gated and ungated SPECT technetium-99m-sestamibi bull's-eyes in normal dogs: comparison with thallium-201. Eisner RL; Martin SE; Leon AR; Schmarkey LS; Worthy MA; Chu TH; Patterson RE J Nucl Med; 1993 Feb; 34(2):281-7. PubMed ID: 8429348 [TBL] [Abstract][Full Text] [Related]
13. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime. Berman DS; Kiat H; Maddahi J Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100 [TBL] [Abstract][Full Text] [Related]
14. Myocardial extraction of technetium-99m-[2-(1-methoxybutyl) isonitrile] in the isolated rabbit heart: a myocardial perfusion agent with high extraction and stable retention. Dahlberg ST; Meerdink DJ; Gilmore MP; Leppo JA J Nucl Med; 1993 Jun; 34(6):927-31. PubMed ID: 8509860 [TBL] [Abstract][Full Text] [Related]
15. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. Maublant JC; Zhang Z; Rapp M; Ollier M; Michelot J; Veyre A J Nucl Med; 1993 Nov; 34(11):1949-52. PubMed ID: 8229240 [TBL] [Abstract][Full Text] [Related]
16. The VEX-test for myocardial scintigraphy with thallium-201 and sestamibi: effect on abdominal background activity. Hurwitz GA; Saddy S; O'Donoghue JP; Ali SA; Powe JE; Husni M; Gravelle DR J Nucl Med; 1995 Jun; 36(6):914-20. PubMed ID: 7769446 [TBL] [Abstract][Full Text] [Related]
17. 99mTc-sestamibi: its clinical role as a viability agent. Marzullo P; Sambuceti G J Nucl Biol Med (1991); 1992; 36(3):259-66. PubMed ID: 1486119 [TBL] [Abstract][Full Text] [Related]
18. Uptake of myocardial imaging agents by rejecting and nonrejecting cardiac transplants. A comparative clinical study of thallium-201, technetium-99m, and gallium-67. Yamamoto S; Bergsland J; Michalek SM; Carroll M; Gona JM; Balu D; Carr EA J Nucl Med; 1989 Sep; 30(9):1464-9. PubMed ID: 2671299 [TBL] [Abstract][Full Text] [Related]
19. Sequential dual-isotope SPECT imaging with thallium-201 and technetium-99m-sestamibi. Heo J; Wolmer I; Kegel J; Iskandrian AS J Nucl Med; 1994 Apr; 35(4):549-53. PubMed ID: 8151373 [TBL] [Abstract][Full Text] [Related]